68% of patients felt they had learnt more about their medicines following an MUR, 58% felt they knew more about side effects and 83% thought the MUR improved their compliance.¹
The Medicines Use Review (MUR) and Prescription Intervention Service introduced in 2005 consists of accredited pharmacists undertaking structured adherence-centred reviews with patients on multiple medicines, particularly those receiving medicines for long-term conditions. National target groups are specified to focus the service towards patients of greatest need.
The MUR is usually conducted face to face in the pharmacy and allows an opportunity for the pharmacist to discuss the patient’s prescribed and non-prescribed medicines to increase their knowledge and understanding. It is a chance for any issues with taking the medicines, missing doses, side effects or patient concerns to be raised. The patient is given advice on medicines taking and with the patient’s permission any clinical issues are referred to their GPs.
2019 update: Interim funding arrangements for Half 1 of 2019/20 were announced on 8th March 2019. As part of these arrangements, it has been agreed that contractors will be paid for a maximum of 200 MURs from 1st April to 30th September 2019. This is because further discussions about the service will form part of the wider negotiations for 2019/20.
Source: PSNC https://psnc.org.uk/services-commissioning/advanced-services/murs/